lawyers weekly logo
Advertisement
Markets
05 November 2025 by Adrian Suljanovic

RBA near neutral as inflation risks linger

Economists have warned inflation risks remain elevated even as the RBA signals policy is sitting near neutral after its latest hold. The Reserve ...
icon

Two fund managers announce C-suite appointments

Schroders Australia and Challenger have both unveiled senior leadership changes, marking significant moves across the ...

icon

Former AI-software company CEO pleads guilty to misleading investors

Former chief executive of AI software company Metigy, David Fairfull, has pleaded guilty after admitting to misleading ...

icon

US trade tensions reducing with its Asian partners

Despite no formal announcement yet from the Trump-Xi summit, recent progress with other Asian trade partners indicates ...

icon

Wall Street wipeout tests faith in AI rally

After a year of remarkable growth driven by the AI boom and a rate-cutting cycle, signs that this easing phase is ...

icon

Corporate watchdog uncovers inconsistent practices in private credit funds

ASIC has unveiled the results of its private credit fund surveillance, revealing funds are demonstrating inconsistent ...

VIEW ALL

GMO, UBS staff defections take mandate toll

  •  
By
  •  
2 minute read

Health fund MBF's financial division, ClearView Retirement Solutions, has dumped GMO Australia and UBS Global Asset Management (UBSGAM) from its Australian shares portfolio.

Health fund MBF's financial division, ClearView Retirement Solutions, has dumped GMO Australia and UBS Global Asset Management (UBSGAM) from its Australian shares portfolio.

ClearView has hired quant manager Dimensional Fund Advisers in their place.

GMO and UBSGAM managed $92 million and $162 million respectively. Dimensional Fund Advisers will manage $190 million.

ClearView's decision to replace UBSGAM and GMO comes at a bad time for both managers, which have lost a series of key staff this year to boutiques.

Former UBSGAM head of Australian equities Paul Fiani left in early 2007 to form his own boutique, Integrity Investment Management. He took portfolio manager Shawn Burns, head of research John Moran and investment analyst Marcus Truman with him.

The manager also lost a $320 million Australian equities mandate with Victorian Funds Management Corporation in September.

GMO lost head of Australian equities Max Cappetta and head of equities research Anthony Corr in September. They left to jointly establish quant boutique Continuum Capital Management with former colleague Brett McElwee.

The manager has lost a series of investment mandates as a result.

ClearView, which is advised by Intech, manages over $2 billion.